Arnulfo Mendoza

4.4k total citations · 1 hit paper
51 papers, 2.8k citations indexed

About

Arnulfo Mendoza is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arnulfo Mendoza has authored 51 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arnulfo Mendoza's work include Sarcoma Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Arnulfo Mendoza is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Arnulfo Mendoza collaborates with scholars based in United States, Canada and China. Arnulfo Mendoza's co-authors include Chand Khanna, Lee J. Helman, Xiaolin Wan, Choh Yeung, Stephen M. Hewitt, Richard Görlick, Ryan D. Cassaday, Osarenoma Olomu, Ling Ren and Na Shen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Arnulfo Mendoza

48 papers receiving 2.7k citations

Hit Papers

The membrane-cytoskeleton... 2004 2026 2011 2018 2004 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Arnulfo Mendoza 1.5k 965 789 636 357 51 2.8k
Choh Yeung 1.1k 0.8× 654 0.7× 656 0.8× 290 0.5× 509 1.4× 23 2.3k
Xiaolin Wan 1.5k 1.0× 549 0.6× 742 0.9× 420 0.7× 147 0.4× 28 2.4k
Ralph M. Wirtz 2.1k 1.4× 1.3k 1.4× 520 0.7× 780 1.2× 374 1.0× 151 3.8k
Olav Engebraaten 1.3k 0.9× 925 1.0× 294 0.4× 700 1.1× 331 0.9× 87 2.7k
Xueshan Qiu 2.1k 1.4× 948 1.0× 489 0.6× 1.1k 1.7× 431 1.2× 145 3.4k
Ralf Brandt 1.9k 1.3× 2.5k 2.6× 1.1k 1.4× 381 0.6× 526 1.5× 27 4.0k
Kazuo Gohji 1.2k 0.8× 837 0.9× 766 1.0× 700 1.1× 241 0.7× 130 2.7k
Noona Ambartsumian 2.2k 1.5× 512 0.5× 670 0.8× 975 1.5× 763 2.1× 42 3.2k
Ling Geng 1.9k 1.3× 981 1.0× 539 0.7× 866 1.4× 232 0.6× 50 3.1k
Nina N. Nupponen 2.2k 1.5× 999 1.0× 1.4k 1.8× 1.1k 1.8× 256 0.7× 64 4.5k

Countries citing papers authored by Arnulfo Mendoza

Since Specialization
Citations

This map shows the geographic impact of Arnulfo Mendoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnulfo Mendoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnulfo Mendoza more than expected).

Fields of papers citing papers by Arnulfo Mendoza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnulfo Mendoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnulfo Mendoza. The network helps show where Arnulfo Mendoza may publish in the future.

Co-authorship network of co-authors of Arnulfo Mendoza

This figure shows the co-authorship network connecting the top 25 collaborators of Arnulfo Mendoza. A scholar is included among the top collaborators of Arnulfo Mendoza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnulfo Mendoza. Arnulfo Mendoza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludwig, Katelyn R., Choh Yeung, Arnulfo Mendoza, et al.. (2024). Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma. Molecular Cancer Therapeutics. 23(8). 1109–1123. 2 indexed citations
2.
Yu, Yanlin, Meng Dai, Liping Huang, et al.. (2023). PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6. iScience. 26(2). 106070–106070. 11 indexed citations
3.
Issaq, Sameer H., Arnulfo Mendoza, Damien Duveau, et al.. (2020). EWS-FLI1–regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth. Molecular Cancer Therapeutics. 19(7). 1520–1529. 25 indexed citations
4.
Liu, Zhihui, Xiyuan Zhang, Haiyan Lei, et al.. (2020). CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG. Nature Communications. 11(1). 911–911. 36 indexed citations
6.
Veschi, Veronica, et al.. (2019). Targeting the Chromosomal Passenger Complex Subunit INCENP Induces Polyploidization, Apoptosis, and Senescence in Neuroblastoma. Cancer Research. 79(19). 4937–4950. 20 indexed citations
7.
Issaq, Sameer H., Arnulfo Mendoza, Stephen D. Fox, & Lee J. Helman. (2019). Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth. Oncogenesis. 8(3). 20–20. 43 indexed citations
8.
Heske, Christine M., Mindy I. Davis, Joshua T. Baumgart, et al.. (2017). Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. Clinical Cancer Research. 23(23). 7301–7311. 50 indexed citations
9.
Morrow, James J., Arnulfo Mendoza, Allyson E. Koyen, et al.. (2016). mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo. Clinical Cancer Research. 22(24). 6129–6141. 22 indexed citations
10.
Heske, Christine M., Choh Yeung, Arnulfo Mendoza, et al.. (2016). The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma. Translational Oncology. 9(6). 540–547. 10 indexed citations
11.
Wan, Xiaolin, Choh Yeung, Christine M. Heske, Arnulfo Mendoza, & Lee J. Helman. (2015). IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. Neoplasia. 17(4). 358–366. 40 indexed citations
12.
Grohar, Patrick J., Choh Yeung, Yves Pommier, et al.. (2013). Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth. Clinical Cancer Research. 20(5). 1190–1203. 60 indexed citations
13.
Ren, Ling, Qingrong Chen, Joseph Briggs, et al.. (2011). Dysregulation of Ezrin Phosphorylation Prevents Metastasis and Alters Cellular Metabolism in Osteosarcoma. Cancer Research. 72(4). 1001–1012. 43 indexed citations
14.
Wu, Yingjie, Pnina Brodt, Hui Sun, et al.. (2010). Insulin-Like Growth Factor-I Regulates the Liver Microenvironment in Obese Mice and Promotes Liver Metastasis. Cancer Research. 70(1). 57–67. 74 indexed citations
15.
Mendoza, Arnulfo, Tanasa S. Osborne, Khan Ma, et al.. (2010). Modeling metastasis biology and therapy in real time in the mouse lung. Journal of Clinical Investigation. 120(8). 2979–2988. 75 indexed citations
16.
Leaner, Virna D., Jeffrey Forris Beecham Chick, Howard Donninger, et al.. (2008). Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma. American Journal Of Pathology. 174(1). 265–275. 32 indexed citations
17.
Briggs, Joseph, Rachel Newman, Karen E. Hoffman, et al.. (2008). Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin‐like growth factor I. International Journal of Cancer. 124(9). 2042–2049. 13 indexed citations
18.
Horak, Christine E., Arnulfo Mendoza, Eleazar Vega-Valle, et al.. (2007). Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2. Cancer Research. 67(24). 11751–11759. 73 indexed citations
19.
Kim, Su Young, Brieanne Midura, Choh Yeung, et al.. (2007). Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clinical & Experimental Metastasis. 25(3). 201–211. 202 indexed citations
20.
Wan, Xiaolin, Na Shen, Arnulfo Mendoza, Chand Khanna, & Lee J. Helman. (2006). CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling. Neoplasia. 8(5). 394–401. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026